Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment
Not Applicable
Completed
- Conditions
- Dry Eye SyndromesDry Eye
- Interventions
- Device: TrueTear
- First Posted Date
- 2017-03-31
- Last Posted Date
- 2018-10-18
- Lead Sponsor
- Oculeve, Inc.
- Target Recruit Count
- 57
- Registration Number
- NCT03097614
- Locations
- πΊπΈ
Andover Eye Associates, Andover, Massachusetts, United States
Tear Production by Nasal Neurostimulation Compared to Active Control
Not Applicable
Completed
- Conditions
- Dry EyeKeratoconjunctivitis SiccaDry Eye Syndromes
- Interventions
- Device: Intranasal Neurostimulator
- First Posted Date
- 2016-11-22
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- Oculeve, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT02970799
Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
Not Applicable
Completed
- Conditions
- Keratoconjunctivitis SiccaDry Eye Syndrome
- Interventions
- Device: Oculeve Intranasal Neurostimulator
- First Posted Date
- 2016-06-14
- Last Posted Date
- 2017-10-25
- Lead Sponsor
- Oculeve, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT02798289
- Locations
- πΊπΈ
Sall Research Medical Center, Artesia, California, United States
πΊπΈAesthetic Eyecare Institute, Newport Beach, California, United States
A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome
Not Applicable
Completed
- Conditions
- Keratoconjunctivitis SiccaDry Eye Syndrome
- Interventions
- Device: Oculeve IntranasalDevice: ShamDevice: Oculeve Extranasal
- First Posted Date
- 2016-02-11
- Last Posted Date
- 2019-04-26
- Lead Sponsor
- Oculeve, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT02680158
- Locations
- πΊπΈ
The Eye Care Group, Waterbury, Connecticut, United States
πΊπΈVirginia Eye Consultants, Norfolk, Virginia, United States
Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator
Not Applicable
Completed
- Conditions
- Dry Eye SyndromesKeratoconjunctivitis Sicca
- Interventions
- Device: Intranasal Lacrimal Neurostimulator (Oculeve)
- First Posted Date
- 2015-08-18
- Last Posted Date
- 2017-10-31
- Lead Sponsor
- Oculeve, Inc.
- Target Recruit Count
- 97
- Registration Number
- NCT02526290
- Locations
- πΊπΈ
Cornea & Cataract Consultants of Arizona, Phoenix, Arizona, United States
πΊπΈAndover Eye Associates, Andover, Massachusetts, United States
πΊπΈTotal Eye Care, Memphis, Tennessee, United States
Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation
Not Applicable
Completed
- Conditions
- Dry Eye Syndromes
- Interventions
- Device: Oculeve Intranasal Lacrimal Neurostimulator
- First Posted Date
- 2015-03-11
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- Oculeve, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT02385292
- Locations
- πΊπΈ
Grutzmacher, Lewis & Sierra, Sacramento, California, United States
πΊπΈBaylor College of Medicine, Department of Ophthalmology, Houston, Texas, United States
The Effect of Electrical Stimulation on Tear Production
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Device: Electrode device
- First Posted Date
- 2012-06-28
- Last Posted Date
- 2014-12-10
- Lead Sponsor
- Oculeve, Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT01630291
- Locations
- π²π½
APEC, La Concepcion, Distrito Federal, Mexico